Prioritizing the Pediatric Dosage Puzzle
How do we fix the course of pediatric medicine to ensure the best treatments for children of all ages?
Rachel Meyers |
People often tell me that it must be incredibly sad and emotional to work in pediatrics. And though it can certainly be distressing at times, kids can be unbelievably tough and their medical journey often finishes with a happy ending. I am always impressed by their resilience and positive attitudes.
I am a Clinical Associate Professor at the Ernest Mario School of Pharmacy at Rutgers University in New Jersey and I also have a practice site at Saint Barnabas Medical Center nearby. As a pharmacist – and from the studies I have been part of, my interactions with children and parents, and my own personal experience as a mother – I think I offer an interesting perspective on the disconnect between drug companies and pediatric patients. There are a few areas that the industry needs to prioritize and improve upon when it comes to pediatric medicines.
Read the full article now
Log in or register to read this article in full and gain access to The Medicine Maker’s entire content archive. It’s FREE and always will be!
Or register now - it’s free and always will be!
You will benefit from:
- Unlimited access to ALL articles
- News, interviews & opinions from leading industry experts
- Receive print (and PDF) copies of The Medicine Maker magazine
Or Login via Social Media
By clicking on any of the above social media links, you are agreeing to our Privacy Notice.